NGL Fine Chem Share Price

NGL Fine Chem Share Price

NSE: NGLFINE
|
Pharmaceuticals

₹ 2,860.10

-₹41.20 (-1.42%)
1D
Last updated 13 Oct, 2026, 15:29 IST

NGL Fine Chem Share Price Today

As of 13 Oct 2026, NGL Fine Chem share price is ₹2,860.10. The stock opened at ₹2,915.80, compared to its previous close of ₹2,901.30. During today's trading session, NGL Fine Chem share price moved in the range of ₹2,830.10 to ₹2,917.60, with an average price of ₹2,873.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,271.00 and a high of ₹3,602.00. On the performance front, NGL Fine Chem share price has increased by 28.28% over the last six months and is up 92.30% on a year-on-year basis.


₹2,830.10
1.42% down today
₹2,917.60
1D LOW
1D HIGH

NGL Fine Chem Returns Calculator

Volume
2,370
Average traded price
₹2,865.05
Last traded time
03:29:58 13 Oct
Last traded quantity
5

Circuit
L
H
₹2,321.10
₹3,481.50
52-week
L
H
₹1,271.00
₹3,602.00
Mkt Cap Cr
1,793.84

P/E
31.36

P/B
5.45

ROA
10.49%
ROE
14.62%

ROCE
15.37%

Quick Ratio
1.37

EV/EBITDA
19.11
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
NGL Fine Chem outperforming all market indices
Step 1 of 5
Valuation
Overvalued
NGL Fine Chem appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
NGL Fine Chem revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About NGL Fine Chem

NGL Fine Chem Share Price
ISIN
INE887E01022
Sector Market Cap
₹ 1,793.84 Cr

NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.

NGL Fine Chem Financial Highlights

  • Revenue: NGL Fine Chem reported revenue of ₹515.68 crore in FY26 vs ₹376.89 crore in FY25. It showed an increase of 36.83% on a yearly basis.
  • Operating Profit: NGL Fine Chem reported an operating profit of ₹63.37 crore in FY26 vs ₹27.71 crore in FY25. It showed an increase of 128.69% on a year-on-year basis.
  • Net Profit: NGL Fine Chem reported a net profit of ₹48.13 crore in FY26 vs ₹21.12 crore in FY25. It showed an increase of 127.89% on a yearly basis.

NGL Fine Chem Quarterly Result Highlights

  • NGL Fine Chem reported revenue of ₹146.59 crore in Jun 2026, compared with ₹151.69 crore in Mar 2026, representing a decrease of 3.36% on a quarter-on-quarter (QoQ) basis.
  • NGL Fine Chem reported an operating profit of ₹24.48 crore in Jun 2026, compared with ₹17.81 crore in Mar 2026, representing an increase of 37.45% on a quarter-on-quarter (QoQ) basis.
  • NGL Fine Chem reported a profit of ₹18.40 crore in Jun 2026, compared with ₹13.49 crore in Mar 2026, reflecting an increase of 36.40% on a QoQ basis.
  • The earnings per share (EPS) of NGL Fine Chem stood at ₹77.90 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.49%
FII
0.05%
Other DII
0.02%
Retail and other
27.43%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.03%
Jun 20260.05%
1 day
-0.82%

1 week
-7.84%

1 month
+8.29%

1 year
+92.30%

3 years
+44.95%

5 years
+53.96%
Day
Open / Close
Change %
12 Oct 26
₹2,956.90 / ₹2,901.30
-0.81%

09 Oct 26
₹3,001.00 / ₹2,925.00
-2.46%

08 Oct 26
₹3,157.10 / ₹2,998.90
-4.32%

07 Oct 26
₹3,122.10 / ₹3,134.20
+0.39%
Show more

NGL Fine Chem Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹500.95₹368.26₹338.69₹278.08
Other Income₹14.73₹8.63₹14.13₹5.53
Total Revenue₹515.68₹376.89₹352.82₹283.61
Total Expenses₹452.32₹349.17₹298.40₹256.25
Profit Before Tax₹63.37₹27.71₹54.42₹27.36
Tax₹15.24₹6.59₹13.10₹6.87
Profit After Tax₹48.13₹21.12₹41.32₹20.50
EPS - Basic₹77.90₹34.19₹66.88₹33.18
EPS - Diluted₹77.90₹34.19₹66.88₹33.18

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹63.37₹27.71₹54.42₹27.36
Income before WC changes₹89.22₹40.83₹66.18₹38.89
Change in Assets-₹59.57-₹20.35-₹59.03₹16.05
Change in Liabilities₹28.91₹18.46₹26.41-₹12.79
Change in WC-₹30.66-₹1.89-₹32.62₹3.26
Cash flow from Operations₹43.32₹32.35₹20.47₹35.29
Cash flow from Investing-₹70.59-₹69.68-₹26.82-₹27.02
Cash flow from Financing₹29.55₹37.47-₹1.08-₹1.08
Total Cash Flow₹2.27₹0.14-₹7.43₹7.18
Cash (Start of the year)₹0.53₹0.40₹7.83₹0.64
Cash (End of the year)₹2.81₹0.53₹0.40₹7.83

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹269.11₹200.80₹142.87₹124.42
Current Assets₹276.39₹233.88₹212.67₹162.66
Total Assets₹545.50₹434.68₹355.54₹287.08
Current Liabilities₹150.01₹118.42₹86.59₹58.29
Net Current Asset₹126.38₹115.46₹126.08₹104.36
Non-Current Liabilities₹66.25₹33.83₹6.32₹6.24
Equity Capital₹329.24₹282.43₹262.63₹222.55
Total Equity & Liabilities₹545.50₹434.68₹355.54₹287.08

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹488.77₹359.29₹328.97₹275.05
Other Income₹14.85₹9.76₹15.90₹7.61
Total Revenue₹503.63₹369.05₹344.87₹282.66
Total Expenses₹449.01₹345.17₹294.17₹256.07
Profit Before Tax₹54.62₹23.88₹50.71₹26.60
Tax₹12.99₹5.75₹12.19₹6.48
Profit After Tax₹41.63₹18.13₹38.52₹20.12
EPS - Basic₹67.39₹29.35₹62.35₹32.57
EPS - Diluted₹67.39₹29.35₹62.35₹32.57

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹54.62₹23.88₹50.71₹26.60
Income before WC changes₹76.55₹32.59₹49.58₹32.51
Change in Assets-₹57.02-₹21.72-₹51.94₹18.04
Change in Liabilities₹28.19₹16.87₹25.68-₹12.18
Change in WC-₹28.83-₹4.85-₹26.26₹5.86
Cash flow from Operations₹34.73₹21.99₹11.14₹31.89
Cash flow from Investing-₹64.57-₹58.20-₹17.49-₹23.62
Cash flow from Financing₹29.87₹36.35-₹1.08-₹1.08
Total Cash Flow₹0.03₹0.14-₹7.44₹7.19
Cash (Start of the year)₹0.52₹0.39₹7.82₹0.64
Cash (End of the year)₹0.55₹0.52₹0.39₹7.82

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹264.38₹198.20₹149.35₹128.92
Current Assets₹265.25₹227.56₹203.69₹159.19
Total Assets₹529.63₹425.76₹353.05₹288.11
Current Liabilities₹144.03₹112.96₹84.36₹56.65
Net Current Asset₹121.22₹114.60₹119.33₹102.54
Non-Current Liabilities₹65.66₹33.19₹5.88₹5.94
Equity Capital₹319.94₹279.61₹262.81₹225.52
Total Equity & Liabilities₹529.63₹425.76₹353.05₹288.11
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
2877.4
8
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 8
Buy orders: 0%
Sell orders: 100%
Bearish
0
Neutral
6
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
49.47
Neutral

ATR (14)
159.61
Neutral

STOCH(9,6)
34.79
Neutral

STOCH RSI (14)
30.36
Neutral

ADX(9)
19.53
Bullish

UO(9)
48.04
Neutral

ROC(12)
2.5
Bullish

WillR(14)
-62.85
Neutral
Period
Simple value
Exponential vaue

5D
3016.3
2960.47

10D
2950.42
2947.45

20D
2856.15
2913.55

50D
2972.49
2923.04

100D
2980.98
2854.55
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
6 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
NGL Fine Chem Share Price
NGL Fine Chem
Pharmaceuticals
Add Stock
Add Another

NGL Fine Chem Share Price FAQs












Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.